Biomaterial technology for tissue engineering applications

被引:253
作者
Tabata, Yasuhiko [1 ]
机构
[1] Kyoto Univ, Dept Biomat, Field Tissue Engn, Inst Frontier Med Sci,Sakyo Ku, Kyoto 6068507, Japan
关键词
biomaterials; drug delivery system; biosignalling molecules; tissue engineering; tissue regeneration; FIBROBLAST-GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; PLATELET-RICH PLASMA; BIODEGRADABLE GELATIN HYDROGEL; IN-VIVO RELEASE; PROTEIN RELEASE; DRUG-DELIVERY; SUSTAINED-RELEASE; TRANSPLANTATION; COLLAGEN;
D O I
10.1098/rsif.2008.0448.focus
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Tissue engineering is a newly emerging biomedical technology and methodology to assist and accelerate the regeneration and repairing of defective and damaged tissues based on the natural healing potentials of patients themselves. For the new therapeutic strategy, it is indispensable to provide cells with a local environment that enhances and regulates their proliferation and differentiation for cell-based tissue regeneration. Biomaterial technology plays an important role in the creation of this cell environment. For example, the biomaterial scaffolds and the drug delivery system (DDS) of biosignalling molecules have been investigated to enhance the proliferation and differentiation of cell potential for tissue regeneration. In addition, the scaffold and DDS technologies contribute to develop the basic research of stem cell biology and medicine as well as obtain a large number of cells with a high quality for cell transplantation therapy. A technology to genetically engineer cells for their functional manipulation is also useful for cell research and therapy. Several examples of tissue engineering applications with the cell scaffold and DDS of growth factors and genes are introduced to emphasize the significance of biomaterial technology in new therapeutic and research fields.
引用
收藏
页码:S311 / S324
页数:14
相关论文
共 97 条
[1]
Protein release from polyphosphazene matrices [J].
Andrianov, AK ;
Payne, LG .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 31 (03) :185-196
[2]
Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice [J].
Aoyama, T ;
Yamamoto, S ;
Kanematsu, A ;
Ogawa, O ;
Tabata, Y .
TISSUE ENGINEERING, 2003, 9 (06) :1289-1299
[3]
Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche [J].
Arai, Fumio ;
Suda, Toshio .
HEMATOPOIETIC STEM CELLS VI, 2007, 1106 :41-53
[4]
Engineering of muscle tissue [J].
Bach, AD ;
Stern-Straeter, J ;
Beier, JP ;
Bannasch, H ;
Stark, GB .
CLINICS IN PLASTIC SURGERY, 2003, 30 (04) :589-+
[5]
Bioartificial pancreas transplantation at prevascularized intermuscular space: Effect of angiogenesis induction on islet survival [J].
Balamurugan, AN ;
Gu, Y ;
Tabata, Y ;
Miyamoto, M ;
Cui, WX ;
Hori, H ;
Satake, A ;
Nagata, N ;
Wang, WJ ;
Inoue, K .
PANCREAS, 2003, 26 (03) :279-285
[6]
Skin tissue engineering [J].
Bannasch, H ;
Föhn, M ;
Unterberg, T ;
Bach, AD ;
Weyand, B ;
Stark, GB .
CLINICS IN PLASTIC SURGERY, 2003, 30 (04) :573-+
[7]
Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells [J].
Benoit, Danielle S. W. ;
Schwartz, Michael P. ;
Durney, Andrew R. ;
Anseth, Kristi S. .
NATURE MATERIALS, 2008, 7 (10) :816-823
[8]
New materials for tissue engineering: towards greater control over the biological response [J].
Chan, Gail ;
Mooney, David J. .
TRENDS IN BIOTECHNOLOGY, 2008, 26 (07) :382-392
[9]
Polymeric growth factor delivery strategies for tissue engineering [J].
Chen, RR ;
Mooney, DJ .
PHARMACEUTICAL RESEARCH, 2003, 20 (08) :1103-1112
[10]
Polysaccharide hydrogels for modified release formulations [J].
Coviello, Tommasina ;
Matricardi, Pietro ;
Marianecci, Carlotta ;
Alhaique, Franco .
JOURNAL OF CONTROLLED RELEASE, 2007, 119 (01) :5-24